Skip to main content
. 2020 Feb 23;56(2):90. doi: 10.3390/medicina56020090

Figure 3.

Figure 3

Enzalutamide effect on viability of prostate cancer cells. (A) LNCaP cells and (B) PC-3 cells exposed to enzalutamide for 48 h. Values are expressed as mean ± S.E.M. Values with different letters (a–e) are significantly different (P < 0.05). Experiments were performed three times.